BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cantan B, Luyt CE, Martin-Loeches I. Influenza Infections and Emergent Viral Infections in Intensive Care Unit. Semin Respir Crit Care Med 2019;40:488-97. [PMID: 31585475 DOI: 10.1055/s-0039-1693497] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Moore P, Esmail F, Qin S, Nand S, Berg S. Hypercoagulability of COVID-19 and Neurological Complications: A Review. J Stroke Cerebrovasc Dis 2021;31:106163. [PMID: 34763262 DOI: 10.1016/j.jstrokecerebrovasdis.2021.106163] [Reference Citation Analysis]
2 Guo J, Xia H, Wang S, Yu L, Zhang H, Chen J, Shi D, Chen Y, Zhang Y, Xu K, Xu X, Sheng J, Qiu Y, Li L. The Artificial-Liver Blood-Purification System Can Effectively Improve Hypercytokinemia for COVID-19. Front Immunol 2020;11:586073. [PMID: 33424838 DOI: 10.3389/fimmu.2020.586073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Qu J, He F, Li H, Lv X. Emergent Virus Reactivation in SARS-CoV-2-Negative Community Acquired Pneumonia Patients During the COVID-19 Pandemic. Front Microbiol 2022;13:758073. [DOI: 10.3389/fmicb.2022.758073] [Reference Citation Analysis]
4 Vorobjeva NV, Sud'ina GF, Chernyak BV. Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19. Front Pharmacol 2021;12:609508. [PMID: 33584318 DOI: 10.3389/fphar.2021.609508] [Reference Citation Analysis]
5 Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Hylander Møller M, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med 2021;49:e1063-143. [PMID: 34605781 DOI: 10.1097/CCM.0000000000005337] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Duan J, Wu Y, Liu C, Yang C, Yang L. Deleterious effects of viral pneumonia on cardiovascular system. European Heart Journal 2020;41:1833-8. [DOI: 10.1093/eurheartj/ehaa325] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
7 Clementi N, Ghosh S, De Santis M, Castelli M, Criscuolo E, Zanoni I, Clementi M, Mancini N. Viral Respiratory Pathogens and Lung Injury. Clin Microbiol Rev 2021;34:e00103-20. [PMID: 33789928 DOI: 10.1128/CMR.00103-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Maldonado MD, Romero-Aibar J. The Pfizer-BNT162b2 mRNA-based vaccine against SARS-CoV-2 may be responsible for awakening the latency of herpes varicella-zoster virus. Brain Behav Immun Health 2021;18:100381. [PMID: 34746880 DOI: 10.1016/j.bbih.2021.100381] [Reference Citation Analysis]
9 Murdaca G, Paladin F, Tonacci A, Isola S, Allegra A, Gangemi S. The Potential Role of Cytokine Storm Pathway in the Clinical Course of Viral Respiratory Pandemic. Biomedicines 2021;9:1688. [PMID: 34829918 DOI: 10.3390/biomedicines9111688] [Reference Citation Analysis]
10 Paolucci S, Cassaniti I, Novazzi F, Fiorina L, Piralla A, Comolli G, Bruno R, Maserati R, Gulminetti R, Novati S, Mojoli F, Baldanti F; San Matteo Pavia COVID-19 Task Force. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. Int J Infect Dis 2021;104:315-9. [PMID: 33359064 DOI: 10.1016/j.ijid.2020.12.051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wang H, He H. The role of high load herpes simplex virus in patients with mechanical ventilation: a real hospital acquired viral lung infection needs antiviral therapy? Crit Care 2020;24:140. [PMID: 32264973 DOI: 10.1186/s13054-020-2815-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Martini F, Champagne E. The Contribution of Human Herpes Viruses to γδ T Cell Mobilisation in Co-Infections. Viruses 2021;13:2372. [PMID: 34960641 DOI: 10.3390/v13122372] [Reference Citation Analysis]
13 Troger A, Burrel S, Pineton de Chambrun M, Schmidt M, Bréchot N, Bomme O, Hékimian G, Combes A, Boutolleau D, Luyt C. Preemptive acyclovir to prevent herpes simplex virus bronchopneumonitis in mechanically ventilated patients with herpes simplex virus oropharyngeal reactivation: An ancillary study of the preemptive treatment for herpesviridae trial. Antiviral Therapy 2022;27:135965352110726. [DOI: 10.1177/13596535211072673] [Reference Citation Analysis]
14 Zhang Y, Cao H, Gong X, Wu Y, Gu P, Kong L, Wu L, Xing J, Shi Z. Clinical Characteristics and Risk Factors for Pulmonary Infection in Emergency ICU Patients. Disease Markers 2022;2022:1-5. [DOI: 10.1155/2022/7711724] [Reference Citation Analysis]
15 Wang H, He H. Correction to: The role of high load herpes simplex virus in patients with mechanical ventilation: a real hospital acquired viral lung infection needs antiviral therapy? Crit Care 2020;24:377. [PMID: 32586333 DOI: 10.1186/s13054-020-03094-z] [Reference Citation Analysis]
16 Chen L, Han X, Li Y, Zhang C, Xing X. Flu-IV score: a predictive tool for assessing the risk of invasive mechanical ventilation in patients with influenza-related pneumonia. BMC Pulm Med 2022;22. [DOI: 10.1186/s12890-022-01833-2] [Reference Citation Analysis]
17 Wu XX, Tang SJ, Yao SH, Zhou YQ, Xiao LL, Cheng LF, Liu FM, Wu NP, Yao HP, Li LJ. The viral distribution and pathological characteristics of BALB/c mice infected with highly pathogenic Influenza H7N9 virus. Virol J 2021;18:237. [PMID: 34844617 DOI: 10.1186/s12985-021-01709-7] [Reference Citation Analysis]
18 Zhang Y, Huang Q, Zhou Z, Xie Y, Li X, Jin W, Wang R. Prognosis of severe lower respiratory tract infected patients with virus detected: a retrospective observational study. Infect Dis (Lond) 2021;53:600-6. [PMID: 33826440 DOI: 10.1080/23744235.2021.1905874] [Reference Citation Analysis]
19 Chen L, Han X, Li Y, Zhang C, Xing X. The severity and risk factors for mortality in immunocompromised adult patients hospitalized with influenza-related pneumonia. Ann Clin Microbiol Antimicrob 2021;20:55. [PMID: 34429126 DOI: 10.1186/s12941-021-00462-7] [Reference Citation Analysis]
20 Mallet F, Diouf L, Meunier B, Perret M, Reynier F, Leissner P, Quemeneur L, Griffiths AD, Moucadel V, Pachot A, Venet F, Monneret G, Lepape A, Rimmelé T, Tan LK, Brengel-Pesce K, Textoris J. Herpes DNAemia and TTV Viraemia in Intensive Care Unit Critically Ill Patients: A Single-Centre Prospective Longitudinal Study. Front Immunol 2021;12:698808. [PMID: 34795661 DOI: 10.3389/fimmu.2021.698808] [Reference Citation Analysis]
21 Colagrossi L, Mattana G, Piccioni L, Cento V, Perno CF. Viral Respiratory Infections: New Tools for a Rapid Diagnosis. Semin Respir Crit Care Med 2021;42:747-58. [PMID: 34918318 DOI: 10.1055/s-0041-1739306] [Reference Citation Analysis]
22 Maraolo AE, Barac A, Cremer OL, Ong DSY. Editorial: Viral Infections in the Intensive Care Unit. Front Med (Lausanne) 2021;8:716824. [PMID: 34277675 DOI: 10.3389/fmed.2021.716824] [Reference Citation Analysis]
23 Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Møller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021;47:1181-247. [PMID: 34599691 DOI: 10.1007/s00134-021-06506-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 12.0] [Reference Citation Analysis]
24 Ambardar SR, Hightower SL, Huprikar NA, Chung KK, Singhal A, Collen JF. Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic. J Clin Med 2021;10:2452. [PMID: 34205928 DOI: 10.3390/jcm10112452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Lin SH, Zhao YS, Zhou DX, Zhou FC, Xu F. Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome. Genes Dis 2020;7:520-7. [PMID: 32837983 DOI: 10.1016/j.gendis.2020.06.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
26 Feng J, Liu L, He Y, Wang M, Zhou D, Wang J. Novel insights into the pathogenesis of virus-induced ARDS: review on the central role of the epithelial-endothelial barrier. Expert Rev Clin Immunol 2021;:1-11. [PMID: 34224287 DOI: 10.1080/1744666X.2021.1951233] [Reference Citation Analysis]
27 Hu Z, Lin J, Chen J, Cai T, Xia L, Liu Y, Song X, He Z. Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants. Front Pharmacol 2021;12:630834. [PMID: 34234668 DOI: 10.3389/fphar.2021.630834] [Reference Citation Analysis]
28 O'Driscoll LS, Martin-Loeches I. Management of Severe Influenza. Semin Respir Crit Care Med 2021;42:771-87. [PMID: 34918320 DOI: 10.1055/s-0041-1735491] [Reference Citation Analysis]
29 Shi L, Xia H, Moore MD, Deng C, Li N, Ren H, Chen Y, Liu J, Du F, Zheng G, Li J, Han Q, Fan W, Ye F, Lin S, Liu Z, Liu H, Wang Y, Yang J, Liu Q, Zhao Y, Chen T. Metagenomic Next-Generation Sequencing in the Diagnosis of HHV-1 Reactivation in a Critically Ill COVID-19 Patient: A Case Report. Front Med (Lausanne) 2021;8:715519. [PMID: 34671616 DOI: 10.3389/fmed.2021.715519] [Reference Citation Analysis]
30 Vermund SH, Pitzer VE. Asymptomatic Transmission and the Infection Fatality Risk for COVID-19: Implications for School Reopening. Clin Infect Dis 2021;72:1493-6. [PMID: 32584967 DOI: 10.1093/cid/ciaa855] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 27.0] [Reference Citation Analysis]
31 Barbalho SM, Matias JN, Flato UAP, Pilon JPG, Bitelli P, Pagani Junior MA, de Carvalho ACA, Haber JFDS, Reis CHB, Goulart RA. What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease? Gastroenterology Res 2021;14:1-12. [PMID: 33737994 DOI: 10.14740/gr1358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]